Accelerated Pathway Opens for GSK’s Pruritus Solution in China’s Rare Liver Disease Population
FDA Grants Priority Review to Enhertu for HER2‑Positive Early Breast Cancer With Residual Disease
Two Intellia Clinical Trials Released by the FDA
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Patient Worthy is honored to share this caregiver story from our friends at the Courageous Parents Network, written by Aisling Melton about her daughter Éabha's fight against brain cancer. Read here:
patientworthy.com/2026/03/12/learning-her-again-a-mothers-understanding-of-baseline/
Accelerated Pathway Opens for GSK's Pruritus Solution in China's Rare Liver Disease Population bit.ly/408bCpe Read now at PatientWorthy.com
#PatientWorthy #RareLiverDisease #PrimaryBiliaryCholangitis #PBC
Patient safety isn't just a priority- it's a promise. During Patient Safety Awareness Week, we reaffirm our commitment to protecting every patient, every time. Because every voice matters, every step counts, and every patient deserves care that is safe, compassionate, and unwavering. 💜 🤗 🫂 #HealthcareSafety #QualityCare #PatientWorthy
